Search





Search





Markets
/
Stocks
/
mist
/

Milestone Pharmaceuticals Inc

MIST

Add to Watchlist

1.190USD

-0.010-0.83%

Close 07-23 16:00（ET）Quotes delayed by 15 min

140.18MMarket Cap

LossP/E TTM

Milestone Pharmaceuticals Inc

1.190

-0.010-0.83%

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

TradingKey Chart

Intraday

30m

Today

-0.83%

5 Days

-4.03%

1 Month

-8.46%

6 Months

-39.90%

Year to Date

-41.09%

1 Year

-25.63%

Key Figures

1.190Open

1.210High

110.00Volume

LossP/E TTM

LossP/E Dynamic

--Dividend TTM

0.00%Turnover Ratio

1.200Prev. Close

1.160Low

102.00Turnover

LossP/E Static

3.89P/B

0.00%Div Yield TTM

-53.49%ROA

3.06052wk High

-0.00Volume Ratio

-41.52MNet Profit

117.79MShares

-0.6386EPS TTM

0.73Beta

-456.88%ROE

0.62552wk Low

4.17%Amplitude

94.12%Gross Margin

140.18MMarket Cap

-1.29Reward/Risk

4.27%Risk Rate

TradingKey Stock Score of Milestone Pharmaceuticals Inc

Currency: USD Updated: 2026-07-23

Key Insights

Milestone Pharmaceuticals Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 162 out of 386 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 6.33.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Milestone Pharmaceuticals Inc's Score

Industry at a Glance

Industry Ranking

162 / 386

Overall Ranking

242 / 4547

Industry

Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

Milestone Pharmaceuticals Inc Highlights

StrengthsRisks

Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 54.60% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 1.55M.

Fairly Valued

The company’s latest PE is -1.88, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 30.89M shares, decreasing 37.71% quarter-over-quarter.

Held by Steven Cohen

Star Investor Steven Cohen holds 921.43K shares of this stock.

Analyst Rating

Based on 6 analysts

Buy

Current Rating

6.333

Target Price

+414.90%

Upside Space

Milestone Pharmaceuticals Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 6 analysts

Buy

Current Rating

6.333

Target Price

+414.90%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

495

Total

Median

Average

Company name

Ratings

Analysts

Milestone Pharmaceuticals Inc

MIST

Beigene Ltd

ONC

argenx SE

ARGX

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

Insmed Inc

INSM

...

Indicators

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.004

Sell

RSI(14)

40.146

Neutral

STOCH(KDJ)(9,3,3)

23.806

Neutral

ATR(14)

0.061

High Vlolatility

CCI(14)

-99.951

Neutral

Williams %R

78.947

Sell

TRIX(12,20)

-0.349

Sell

StochRSI(14)

68.048

Neutral

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

1.197

Sell

MA10

1.236

Sell

MA20

1.265

Sell

MA50

1.336

Sell

MA100

1.523

Sell

MA200

1.788

Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Milestone Pharmaceuticals Inc Info

Ticker SymbolMIST

CompanyMilestone Pharmaceuticals Inc

CEOOliveto (Joseph)

Websitehttps://www.milestonepharma.com

Shareholders

Shareholders

Proportion

Simplify Asset Management Inc

4.70%

Propel Bio Management, LLC

4.28%

Adage Capital Management, L.P.

2.35%

Oliveto (Joseph Gerard)

2.18%

RTW Investments L.P.

2.09%

Other

84.39%

Popular Instruments

FAQs

What is the current price of Milestone Pharmaceuticals Inc (MIST)?



The current price of Milestone Pharmaceuticals Inc (MIST) is 1.20.

What is the symbol of Milestone Pharmaceuticals Inc?



The ticker symbol of Milestone Pharmaceuticals Inc is MIST.

What is the 52-week high of Milestone Pharmaceuticals Inc?



The 52-week high of Milestone Pharmaceuticals Inc is 3.06.

What is the 52-week low of Milestone Pharmaceuticals Inc?



The 52-week low of Milestone Pharmaceuticals Inc is 0.63.

What is the market capitalization of Milestone Pharmaceuticals Inc?



The market capitalization of Milestone Pharmaceuticals Inc is 140.76M.

Is Milestone Pharmaceuticals Inc (MIST) currently rated as Buy, Hold, or Sell?



According to analysts, Milestone Pharmaceuticals Inc (MIST) has an overall rating of Buy, with a price target of 6.33.

What is the Earnings Per Share (EPS TTM) of Milestone Pharmaceuticals Inc (MIST)?



The Earnings Per Share (EPS TTM) of Milestone Pharmaceuticals Inc (MIST) is -0.75.